Azalea Vision Secures Up to €7.5 Million from European Innovation Council to Advance Smart Contact Lens Platform Toward Clinical Development Belgian health technology innovator Azalea Vision has secured a major boost for the development of its pioneering smart contact lens…
Colossal Foundation and University of Tasmania Launch Multi-Pronged Initiative to Combat Deadly Tasmanian Devil Facial Tumour Disease The Colossal Foundation, the nonprofit conservation organization established by Colossal Biosciences, has announced a strategic partnership with the University of Tasmania to accelerate…
Samsung Bioepis Reports Positive Phase 1 and Phase 3 Results for SB27, Its Proposed Pembrolizumab Biosimilar Samsung Bioepis Co., Ltd. has announced encouraging topline results from its Phase 1 and Phase 3 clinical development program for SB27, the company’s proposed…
Genentech’s Enspryng Receives FDA Priority Review for Thyroid Eye Disease, Advancing a Potential New Treatment Option Genentech, a member of the Roche Group, has announced that the U.S. Food and Drug Administration (FDA) has accepted for review its supplemental Biologics…
Merck Expands Access to New HIV Treatment IDVYNSO™ Through Agreement with the ADAP Crisis Task Force Merck, known as MSD outside the United States and Canada, has announced a new agreement with the ADAP Crisis Task Force (ACTF) aimed at…
Epicrispr Biotechnologies Reports Promising Phase 1/2 Data Showing Increased Muscle Volume with EPI-321 in Patients with Facioscapulohumeral Muscular Dystrophy Epicrispr Biotechnologies, a clinical-stage biotechnology company focused on developing epigenetic therapies, has announced encouraging interim results from its ongoing Phase 1/2…
MaaT Pharma to Seek EMA Re-Examination After CHMP Issues Negative Opinion on Conditional Marketing Application for Xervyteg® in Acute Graft-versus-Host Disease Clinical-stage biotechnology company MaaT Pharma has announced that the Committee for Medicinal Products for Human Use (CHMP) of the…
MRM Health Strengthens Board of Directors with Two Industry Veterans as Lead Microbiome Therapy Advances Toward Late-Stage Development MRM Health, a clinical-stage biotechnology company focused on developing microbiome-based therapeutics for immune-mediated diseases, has announced the appointment of two highly accomplished…
Carnegie Mellon-Led Team Secures Up to $39.3 Million ARPA-H Award to Develop OMEGA Fetal Monitoring System Carnegie Mellon University is spearheading a major multi-institution research initiative aimed at transforming how clinicians detect fetal distress during labor and delivery, after securing…
AstraZeneca and YMCA of the USA Launch Five-Year Partnership to Expand Cancer Screening, Early Detection and Survivorship Support Across the U.S. AstraZeneca and YMCA of the USA (Y-USA) have announced a new five-year partnership aimed at expanding cancer education, improving…
Javelin Biotech Publishes Multi-Tissue Chip and PBPK Study Showing Potential to Predict Human Drug Pharmacokinetics Without Animal Data Javelin Biotech has announced the publication of a new scientific study that highlights the potential of advanced multi-microphysiological systems (multi-MPS) and computational…
HighRes and Waters Biosciences Partner to Bring Robotic Automation to Flow Cytometry Workflows HighRes has announced a strategic collaboration with Waters Biosciences aimed at expanding robotic automation capabilities for flow cytometry workflows, a move designed to help laboratories increase throughput,…